ABT logo

Abbott Laboratories (ABT) Return On Equity

Annual ROE

30.91%
+15.80%+104.57%

December 1, 2024

Summary

Performance

1-Year Change

+104.57%

3-Year Change

+50.85%

5-Year Change

+159.97%

15-Year Change

+1579.89%

ABT ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.74%
ABT annual return on equity is higher than 84.74% of companies in Healthcare sector

High & Low

All-time High

43.42%
ABT annual return on equity is currently -28.81% below its historical high of 43.42%

3-Year Low

15.11%
ABT annual return on equity is currently +104.57% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
ABT previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
ABT next annual earnings announcement has not yet been scheduled

OtherABTprofitabilitymetrics:

Annual Revenue

$41.95 B
ABT annual revenue is $41.95 billion

Annual Net Income

$13.40 B
ABT annual net profit is $13.40 billion

Annual EPS

$7.64
ABT annual earnings per share is $7.64

Annual ROA

17.33%
ABT annual return on assets is 17.33%

Quarterly ROE

32.63%
+17.85%+120.77%

December 1, 2024

Summary

Performance

3-Month Change

+120.77%

1-Year Change

+114.39%

3-Year Change

+114.39%

5-Year Change

+114.39%

ABT Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

86.71%
ABT quarterly return on equity is higher than 86.71% of companies in Healthcare sector

High & Low

All-time High

43.99%
ABT quarterly return on equity is currently -25.82% below its historical high of 43.99%

3-Year Low

13.94%
ABT quarterly return on equity is currently +134.07% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
ABT previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

Apr 17, 2025
ABT next earnings announcement is scheduled for Apr 17, 2025

OtherABTprofitabilitymetrics:

Quarterly Revenue

$10.97 B
ABT quarterly revenue is $10.97 billion

Quarterly Net Income

$9.23 B
ABT quarterly net profit is $9.23 billion

Quarterly EPS

$5.27
ABT quarterly earnings per share is $5.27

Quarterly ROA

17.89%
ABT quarterly return on assets is 17.89%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

30.91%
ABT annual return on equity is 30.91%

Annual Net Income

$13.40 B
ABT annual net profit is $13.40 billion

Annual Shareholders Equity

$47.66 B
ABT annual stockholders equity is $47.66 billion

ABT ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+104.6%+114.4%
3 y3 years+50.9%+114.4%
5 y5 years+160.0%+114.4%

ABT ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+104.6%at high+134.1%
5 y5-yearat high+160.0%at high+228.3%
alltimeall time-28.8%+1579.9%-25.8%+2075.3%

Abbott Laboratories ROE History

DateAnnualQuarterly
Dec 2024
30.91%(+104.6%)
32.63%(+120.8%)
Sep 2024
-
14.78%(+2.4%)
Jun 2024
-
14.43%(-2.5%)
Mar 2024
-
14.80%(-2.8%)
Dec 2023
15.11%(-20.5%)
15.22%(+9.2%)
Sep 2023
-
13.94%(-0.5%)
Jun 2023
-
14.01%(-11.9%)
Mar 2023
-
15.91%(-16.9%)
Dec 2022
19.01%(-7.2%)
19.14%(-13.2%)
Sep 2022
-
22.05%(-8.7%)
Jun 2022
-
24.16%(+8.9%)
Mar 2022
-
22.18%(+7.6%)
Dec 2021
20.49%(+46.6%)
20.62%(-4.9%)
Sep 2021
-
21.68%(+11.0%)
Jun 2021
-
19.53%(+8.9%)
Mar 2021
-
17.93%(+25.4%)
Dec 2020
13.98%(+17.6%)
14.30%(+32.0%)
Sep 2020
-
10.83%(+9.0%)
Jun 2020
-
9.94%(-12.9%)
Mar 2020
-
11.41%(-2.8%)
Dec 2019
11.89%(+55.2%)
11.74%(+11.7%)
Sep 2019
-
10.51%(+12.9%)
Jun 2019
-
9.31%(+10.2%)
Mar 2019
-
8.45%(+10.7%)
Dec 2018
7.66%(+316.3%)
7.63%(+169.6%)
Sep 2018
-
2.83%(-3.7%)
Jun 2018
-
2.94%(+96.0%)
Mar 2018
-
1.50%(-7.4%)
Dec 2017
1.84%(-72.4%)
1.62%(-78.9%)
Sep 2017
-
7.67%(+64.6%)
Jun 2017
-
4.66%(-28.9%)
Mar 2017
-
6.55%(-2.1%)
Dec 2016
6.66%(-67.7%)
6.69%(+2.8%)
Sep 2016
-
6.51%(-38.6%)
Jun 2016
-
10.61%(-5.9%)
Mar 2016
-
11.28%(-44.2%)
Dec 2015
20.59%(+111.4%)
20.23%(-1.6%)
Sep 2015
-
20.55%(+3.2%)
Jun 2015
-
19.91%(+7.9%)
Mar 2015
-
18.45%(+89.2%)
Dec 2014
9.74%(-1.5%)
9.75%(+18.2%)
Sep 2014
-
8.25%(-18.2%)
Jun 2014
-
10.09%(-1.3%)
Mar 2014
-
10.22%(-3.9%)
Dec 2013
9.89%(-57.4%)
10.64%(-14.0%)
Sep 2013
-
12.37%(-23.9%)
Jun 2013
-
16.25%(-21.8%)
Mar 2013
-
20.77%(-10.4%)
Dec 2012
23.23%(+16.2%)
23.19%(-10.2%)
Sep 2012
-
25.81%(+32.8%)
Jun 2012
-
19.43%(-4.1%)
Mar 2012
-
20.27%(+5.6%)
Dec 2011
20.00%(-1.3%)
19.19%(+1.3%)
Sep 2011
-
18.94%(-14.9%)
Jun 2011
-
22.26%(+9.1%)
Mar 2011
-
20.40%(-4.6%)
Dec 2010
20.26%(-28.7%)
21.39%(-3.3%)
Sep 2010
-
22.12%(-12.4%)
Jun 2010
-
25.26%(-1.8%)
Mar 2010
-
25.73%(-10.7%)
Dec 2009
28.43%(+2.8%)
28.82%(-3.5%)
Sep 2009
-
29.87%(+4.7%)
Jun 2009
-
28.53%(-2.7%)
Mar 2009
-
29.32%(+10.0%)
Dec 2008
27.66%(+22.1%)
26.65%(+5.1%)
Sep 2008
-
25.36%(+3.9%)
Jun 2008
-
24.40%(+2.8%)
Mar 2008
-
23.74%(+1.5%)
Dec 2007
22.66%(+87.9%)
23.39%(+81.9%)
Sep 2007
-
12.86%(-0.5%)
Jun 2007
-
12.92%(+22.8%)
Mar 2007
-
10.52%(-9.6%)
Dec 2006
12.06%(-48.6%)
11.64%(-45.7%)
Sep 2006
-
21.43%(-0.6%)
Jun 2006
-
21.56%(-9.1%)
Mar 2006
-
23.71%(+0.6%)
Dec 2005
23.47%(-0.6%)
23.56%(-2.0%)
Sep 2005
-
24.04%(-5.5%)
Jun 2005
-
25.44%(+6.1%)
Mar 2005
-
23.97%(-1.2%)
DateAnnualQuarterly
Dec 2004
23.62%(+1.8%)
24.26%(-2.8%)
Sep 2004
-
24.95%(-0.3%)
Jun 2004
-
25.03%(+11.3%)
Mar 2004
-
22.48%(-3.9%)
Dec 2003
23.20%(-18.1%)
23.39%(+8.2%)
Sep 2003
-
21.62%(-1.9%)
Jun 2003
-
22.03%(-16.5%)
Mar 2003
-
26.39%(-6.3%)
Dec 2002
28.33%(+61.1%)
28.16%(-3.6%)
Sep 2002
-
29.20%(-1.0%)
Jun 2002
-
29.50%(-1.6%)
Mar 2002
-
29.98%(+66.2%)
Dec 2001
17.59%(-49.5%)
18.04%(-9.9%)
Sep 2001
-
20.02%(-2.5%)
Jun 2001
-
20.53%(-9.8%)
Mar 2001
-
22.77%(-34.0%)
Dec 2000
34.83%(-6.1%)
34.51%(-1.5%)
Sep 2000
-
35.05%(+2.2%)
Jun 2000
-
34.30%(-4.3%)
Mar 2000
-
35.83%(-5.2%)
Dec 1999
37.11%(-14.5%)
37.80%(-4.9%)
Sep 1999
-
39.76%(-7.0%)
Jun 1999
-
42.73%(-2.1%)
Mar 1999
-
43.66%(-0.6%)
Dec 1998
43.42%(+2.5%)
43.92%(-0.2%)
Sep 1998
-
43.99%(+1.0%)
Jun 1998
-
43.56%(+1.2%)
Mar 1998
-
43.06%(+1.3%)
Dec 1997
42.35%(+3.7%)
42.51%(+0.8%)
Sep 1997
-
42.17%(+1.7%)
Jun 1997
-
41.47%(+1.0%)
Mar 1997
-
41.04%(+0.9%)
Dec 1996
40.84%(+2.1%)
40.67%(+0.0%)
Sep 1996
-
40.65%(+0.0%)
Jun 1996
-
40.64%(+0.3%)
Mar 1996
-
40.52%(+1.2%)
Dec 1995
39.99%(+1.8%)
40.03%(+0.5%)
Sep 1995
-
39.84%(-0.2%)
Jun 1995
-
39.91%(+0.5%)
Mar 1995
-
39.70%(+1.0%)
Dec 1994
39.27%(-1.5%)
39.31%(-0.4%)
Sep 1994
-
39.45%(+0.2%)
Jun 1994
-
39.39%(-0.2%)
Mar 1994
-
39.45%(-0.8%)
Dec 1993
39.85%(+5.3%)
39.77%(+1.2%)
Sep 1993
-
39.31%(+1.4%)
Jun 1993
-
38.75%(+0.6%)
Mar 1993
-
38.50%(+2.7%)
Dec 1992
37.83%(+4.9%)
37.50%(+0.8%)
Sep 1992
-
37.22%(-0.2%)
Jun 1992
-
37.28%(+1.6%)
Mar 1992
-
36.71%(+0.7%)
Dec 1991
36.07%(+3.8%)
36.46%(-0.1%)
Sep 1991
-
36.51%(+1.1%)
Jun 1991
-
36.12%(+1.3%)
Mar 1991
-
35.65%(+1.5%)
Dec 1990
34.74%(+4.9%)
35.12%(+0.1%)
Sep 1990
-
35.09%(-2.0%)
Jun 1990
-
35.80%(-4.7%)
Mar 1990
-
37.55%(-4.5%)
Dec 1989
33.13%(+0.4%)
39.32%(+16.9%)
Sep 1989
-
33.64%(+3.0%)
Jun 1989
-
32.67%(+3.5%)
Mar 1989
-
31.56%(-17.7%)
Dec 1988
33.00%(+1.0%)
38.33%(+11.5%)
Sep 1988
-
34.38%(+3.8%)
Jun 1988
-
33.12%(+4.6%)
Mar 1988
-
31.67%(-8.1%)
Dec 1987
32.67%(+10.3%)
34.45%(+1.6%)
Sep 1987
-
33.90%(+4.0%)
Jun 1987
-
32.61%(+3.9%)
Mar 1987
-
31.40%(+1.7%)
Dec 1986
29.62%(+10.6%)
30.87%(+10.8%)
Sep 1986
-
27.87%(+3.2%)
Jun 1986
-
27.01%(+3.8%)
Mar 1986
-
26.01%(+4.6%)
Dec 1985
26.79%(+6.6%)
24.87%(-10.8%)
Sep 1985
-
27.89%(+3.5%)
Jun 1985
-
26.94%(+3.5%)
Mar 1985
-
26.02%(+3.6%)
Dec 1984
25.12%
25.12%

FAQ

  • What is Abbott Laboratories annual return on equity?
  • What is the all time high annual ROE for Abbott Laboratories?
  • What is Abbott Laboratories annual ROE year-on-year change?
  • What is Abbott Laboratories quarterly return on equity?
  • What is the all time high quarterly ROE for Abbott Laboratories?
  • What is Abbott Laboratories quarterly ROE year-on-year change?

What is Abbott Laboratories annual return on equity?

The current annual ROE of ABT is 30.91%

What is the all time high annual ROE for Abbott Laboratories?

Abbott Laboratories all-time high annual return on equity is 43.42%

What is Abbott Laboratories annual ROE year-on-year change?

Over the past year, ABT annual return on equity has changed by +15.80% (+104.57%)

What is Abbott Laboratories quarterly return on equity?

The current quarterly ROE of ABT is 32.63%

What is the all time high quarterly ROE for Abbott Laboratories?

Abbott Laboratories all-time high quarterly return on equity is 43.99%

What is Abbott Laboratories quarterly ROE year-on-year change?

Over the past year, ABT quarterly return on equity has changed by +17.41% (+114.39%)